Literature DB >> 495691

Lung injury induced by leukocytic proteases.

A Janoff, R White, H Carp, S Harel, R Dearing, D Lee.   

Abstract

Human polymorphonuclear neutrophilic leukocytes (PMNs) contain large amounts of neutral proteases that can degrade elastin, collagen, proteoglycan, and basement membrane. The instillation of one of the purified enzymes (elastase) into dog lungs in vivo causes degradation of elastic fibers and other alveolar septal components and results in anatomic changes similar to those of human pulmonary emphysema. Cigarette smoking is a major risk factor associated with pulmonary emphysema in man. One mechanism for this association may be interference with the regulation of PMN elastase activity by alveolar antiproteases. This possibility is supported by the observation that the oxidizing activity of tobacco smoke inactivates alpha 1-proteinase inhibitor in vitro. Macrophages also secrete an elastolytic protease, albeit at low levels. The short-term exposure of cultured mouse macrophages to cigarette smoke augments the rate of elastase secretion by these cells. Mouse macrophage elastase is not inhibited by alpha 1-proteinase inhibitor or alpha 2-macroglobulin. This unusual property of macrophage elastase may facilitate its attack upon elastin over prolonged intervals despite very low levels of macrophage elastase production. A unified hypothesis of lung injury in pulmonary emphysema is presented, involving both PMN and macrophage elastases and the actions of cigarette smoke. (Am J Pathol 97:111--136, 1979).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495691      PMCID: PMC2042389     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  The effects in vivo and in vitro of oxidative damage to purified alpha1-antitrypsin and to the enzyme-inhibiting activity of plasma.

Authors:  A B Cohen
Journal:  Am Rev Respir Dis       Date:  1979-06

2.  Proteases from purulent sputum. Purification and properties of the elastase and chymotrypsin-like enzymes.

Authors:  D Y Twumasi; I E Liener
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

3.  Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants.

Authors:  H Carp; A Janoff
Journal:  Am Rev Respir Dis       Date:  1978-09

4.  Effect of tobacco smoke condensate on the aerial oxidation of cysteine.

Authors:  B L TONGE
Journal:  Nature       Date:  1962-04-21       Impact factor: 49.962

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers.

Authors:  R J Rodriguez; R R White; R M Senior; E A Levine
Journal:  Science       Date:  1977-10-21       Impact factor: 47.728

7.  The dual nature of the reaction between porcine elastase and human plasma alpha1 proteinase inhibitor.

Authors:  S Satoh; T Kurecki; L F Kress; M Laskowski
Journal:  Biochem Biophys Res Commun       Date:  1979-01-15       Impact factor: 3.575

8.  Effect of oxidation of methionine residues in chicken ovoinhibitor on its inhibitory activities against trypsin, chymotrypsin, and elastase.

Authors:  Y Shechter; Y Burnstein; A Gertler
Journal:  Biochemistry       Date:  1977-03-08       Impact factor: 3.162

9.  In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.

Authors:  H Carp; A Janoff
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

10.  Elastase secretion by peritoneal exudative and alveolar macrophages.

Authors:  R White; H S Lin; C Kuhn
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  39 in total

1.  Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.

Authors:  R C Hubbard; F Ogushi; G A Fells; A M Cantin; S Jallat; M Courtney; R G Crystal
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Co-culture of primary pulmonary cells to model alveolar injury and translocation of proteins.

Authors:  J B Mangum; J I Everitt; J C Bonner; L R Moore; A R Brody
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

Review 3.  The stumbling block in lung repair of emphysema: elastic fiber assembly.

Authors:  Adrian Shifren; Robert P Mecham
Journal:  Proc Am Thorac Soc       Date:  2006-07

4.  Inflammation generating potential of long and short fibre amosite asbestos samples.

Authors:  K Donaldson; G M Brown; D M Brown; R E Bolton; J M Davis
Journal:  Br J Ind Med       Date:  1989-04

5.  The use of monoclonal antibodies to distinguish several chemically modified forms of human alpha 1-proteinase inhibitor.

Authors:  X J Zhu; S K Chan
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

6.  Inflammatory responses in lungs of rats inhaling coalmine dust: enhanced proteolysis of fibronectin by bronchoalveolar leukocytes.

Authors:  G M Brown; K Donaldson
Journal:  Br J Ind Med       Date:  1989-12

Review 7.  Structure and function of the anaphylatoxins.

Authors:  T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1984

Review 8.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

9.  Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

Authors:  J E Gadek; G A Fells; R L Zimmerman; S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Self-labeling of human polymorphonuclear leucocyte myeloperoxidase with 125iodine.

Authors:  G Deby-Dupont; J Pincemail; A Thirion; C Deby; M Lamy; P Franchimont
Journal:  Experientia       Date:  1991-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.